DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body€™s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
Market Analysis and Insights: Global DNA Repair Drugs Market
The global DNA Repair Drugs market size is projected to reach US$ 1993.3 million by 2027, from US$ 723.5 million in 2020, at a CAGR of 18.4% during 2021-2027.
Global DNA Repair Drugs Scope and Segment
The global DNA Repair Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DNA Repair Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
PARP Inhibitors
Other
By the end users/application, this report covers the following segments
Oncological
Stroke
Competitive Landscape:
The report provides a list of all the key players in the DNA Repair Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The DNA Repair Drugs key manufacturers in this market include:
4SC AG
ARCAGY/ GINECO GROUP
Bristol Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech
Georgetown University
German Breast Group
GlaxoSmithKline
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
Market Analysis and Insights: Global DNA Repair Drugs Market
The global DNA Repair Drugs market size is projected to reach US$ 1993.3 million by 2027, from US$ 723.5 million in 2020, at a CAGR of 18.4% during 2021-2027.
Global DNA Repair Drugs Scope and Segment
The global DNA Repair Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DNA Repair Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
PARP Inhibitors
Other
By the end users/application, this report covers the following segments
Oncological
Stroke
Competitive Landscape:
The report provides a list of all the key players in the DNA Repair Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The DNA Repair Drugs key manufacturers in this market include:
4SC AG
ARCAGY/ GINECO GROUP
Bristol Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech
Georgetown University
German Breast Group
GlaxoSmithKline
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
1 DNA Repair Drugs Market Overview
1.1 DNA Repair Drugs Product Overview
1.2 DNA Repair Drugs Market Segment by Type
1.2.1 PARP Inhibitors
1.2.2 Other
1.3 Global DNA Repair Drugs Market Size by Type
1.3.1 Global DNA Repair Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global DNA Repair Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global DNA Repair Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global DNA Repair Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global DNA Repair Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global DNA Repair Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global DNA Repair Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global DNA Repair Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global DNA Repair Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America DNA Repair Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe DNA Repair Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific DNA Repair Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America DNA Repair Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa DNA Repair Drugs Sales Breakdown by Type (2016-2021)
2 Global DNA Repair Drugs Market Competition by Company
2.1 Global Top Players by DNA Repair Drugs Sales (2016-2021)
2.2 Global Top Players by DNA Repair Drugs Revenue (2016-2021)
2.3 Global Top Players DNA Repair Drugs Price (2016-2021)
2.4 Global Top Manufacturers DNA Repair Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 DNA Repair Drugs Market Competitive Situation and Trends
2.5.1 DNA Repair Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by DNA Repair Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into DNA Repair Drugs Market
2.8 Key Manufacturers DNA Repair Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 DNA Repair Drugs Status and Outlook by Region
3.1 Global DNA Repair Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global DNA Repair Drugs Historic Market Size by Region
3.2.1 Global DNA Repair Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global DNA Repair Drugs Sales in Value by Region (2016-2021)
3.2.3 Global DNA Repair Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global DNA Repair Drugs Forecasted Market Size by Region
3.3.1 Global DNA Repair Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global DNA Repair Drugs Sales in Value by Region (2022-2027)
3.3.3 Global DNA Repair Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global DNA Repair Drugs by Application
4.1 DNA Repair Drugs Market Segment by Application
4.1.1 Oncological
4.1.2 Stroke
4.2 Global DNA Repair Drugs Market Size by Application
4.2.1 Global DNA Repair Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global DNA Repair Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global DNA Repair Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global DNA Repair Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global DNA Repair Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global DNA Repair Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global DNA Repair Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global DNA Repair Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global DNA Repair Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America DNA Repair Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe DNA Repair Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific DNA Repair Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America DNA Repair Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa DNA Repair Drugs Sales Breakdown by Application (2016-2021)
5 North America DNA Repair Drugs by Country
5.1 North America DNA Repair Drugs Historic Market Size by Country
5.1.1 North America DNA Repair Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America DNA Repair Drugs Sales in Value by Country (2016-2021)
5.2 North America DNA Repair Drugs Forecasted Market Size by Country
5.2.1 North America DNA Repair Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America DNA Repair Drugs Sales in Value by Country (2022-2027)
6 Europe DNA Repair Drugs by Country
6.1 Europe DNA Repair Drugs Historic Market Size by Country
6.1.1 Europe DNA Repair Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe DNA Repair Drugs Sales in Value by Country (2016-2021)
6.2 Europe DNA Repair Drugs Forecasted Market Size by Country
6.2.1 Europe DNA Repair Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe DNA Repair Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific DNA Repair Drugs by Region
7.1 Asia-Pacific DNA Repair Drugs Historic Market Size by Region
7.1.1 Asia-Pacific DNA Repair Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific DNA Repair Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific DNA Repair Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific DNA Repair Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific DNA Repair Drugs Sales in Value by Region (2022-2027)
8 Latin America DNA Repair Drugs by Country
8.1 Latin America DNA Repair Drugs Historic Market Size by Country
8.1.1 Latin America DNA Repair Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America DNA Repair Drugs Sales in Value by Country (2016-2021)
8.2 Latin America DNA Repair Drugs Forecasted Market Size by Country
8.2.1 Latin America DNA Repair Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America DNA Repair Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa DNA Repair Drugs by Country
9.1 Middle East and Africa DNA Repair Drugs Historic Market Size by Country
9.1.1 Middle East and Africa DNA Repair Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa DNA Repair Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa DNA Repair Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa DNA Repair Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa DNA Repair Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in DNA Repair Drugs Business
10.1 4SC AG
10.1.1 4SC AG Corporation Information
10.1.2 4SC AG Introduction and Business Overview
10.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 4SC AG DNA Repair Drugs Products Offered
10.1.5 4SC AG Recent Development
10.2 ARCAGY/ GINECO GROUP
10.2.1 ARCAGY/ GINECO GROUP Corporation Information
10.2.2 ARCAGY/ GINECO GROUP Introduction and Business Overview
10.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 4SC AG DNA Repair Drugs Products Offered
10.2.5 ARCAGY/ GINECO GROUP Recent Development
10.3 Bristol Myers Squibb
10.3.1 Bristol Myers Squibb Corporation Information
10.3.2 Bristol Myers Squibb Introduction and Business Overview
10.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
10.3.5 Bristol Myers Squibb Recent Development
10.4 British Columbia Cancer Agency
10.4.1 British Columbia Cancer Agency Corporation Information
10.4.2 British Columbia Cancer Agency Introduction and Business Overview
10.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
10.4.5 British Columbia Cancer Agency Recent Development
10.5 Cambridge University Hospitals NHS Foundation Trust
10.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
10.5.2 Cambridge University Hospitals NHS Foundation Trust Introduction and Business Overview
10.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
10.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
10.6 Genentech
10.6.1 Genentech Corporation Information
10.6.2 Genentech Introduction and Business Overview
10.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Genentech DNA Repair Drugs Products Offered
10.6.5 Genentech Recent Development
10.7 Georgetown University
10.7.1 Georgetown University Corporation Information
10.7.2 Georgetown University Introduction and Business Overview
10.7.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Georgetown University DNA Repair Drugs Products Offered
10.7.5 Georgetown University Recent Development
10.8 German Breast Group
10.8.1 German Breast Group Corporation Information
10.8.2 German Breast Group Introduction and Business Overview
10.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 German Breast Group DNA Repair Drugs Products Offered
10.8.5 German Breast Group Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Corporation Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Jiangsu Hengrui Medicine
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 DNA Repair Drugs Product Category, Application and Specification
10.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Jiangsu Hengrui Medicine Recent Development
10.11 Johnson & Johnson
10.11.1 Johnson & Johnson Corporation Information
10.11.2 Johnson & Johnson Introduction and Business Overview
10.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Johnson & Johnson DNA Repair Drugs Products Offered
10.11.5 Johnson & Johnson Recent Development
10.12 Jonsson Comprehensive Cancer Center
10.12.1 Jonsson Comprehensive Cancer Center Corporation Information
10.12.2 Jonsson Comprehensive Cancer Center Introduction and Business Overview
10.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Products Offered
10.12.5 Jonsson Comprehensive Cancer Center Recent Development
10.13 Karyopharm Therapeutics
10.13.1 Karyopharm Therapeutics Corporation Information
10.13.2 Karyopharm Therapeutics Introduction and Business Overview
10.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Karyopharm Therapeutics DNA Repair Drugs Products Offered
10.13.5 Karyopharm Therapeutics Recent Development
10.14 KuDOS Pharmaceuticals
10.14.1 KuDOS Pharmaceuticals Corporation Information
10.14.2 KuDOS Pharmaceuticals Introduction and Business Overview
10.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Products Offered
10.14.5 KuDOS Pharmaceuticals Recent Development
10.15 National Health Service
10.15.1 National Health Service Corporation Information
10.15.2 National Health Service Introduction and Business Overview
10.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.15.4 National Health Service DNA Repair Drugs Products Offered
10.15.5 National Health Service Recent Development
10.16 National Institutes of Health
10.16.1 National Institutes of Health Corporation Information
10.16.2 National Institutes of Health Introduction and Business Overview
10.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.16.4 National Institutes of Health DNA Repair Drugs Products Offered
10.16.5 National Institutes of Health Recent Development
10.17 Tesaro
10.17.1 Tesaro Corporation Information
10.17.2 Tesaro Introduction and Business Overview
10.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Tesaro DNA Repair Drugs Products Offered
10.17.5 Tesaro Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 DNA Repair Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 DNA Repair Drugs Industrial Chain Analysis
11.4 DNA Repair Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 DNA Repair Drugs Distributors
12.3 DNA Repair Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 DNA Repair Drugs Product Overview
1.2 DNA Repair Drugs Market Segment by Type
1.2.1 PARP Inhibitors
1.2.2 Other
1.3 Global DNA Repair Drugs Market Size by Type
1.3.1 Global DNA Repair Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global DNA Repair Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global DNA Repair Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global DNA Repair Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global DNA Repair Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global DNA Repair Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global DNA Repair Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global DNA Repair Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global DNA Repair Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America DNA Repair Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe DNA Repair Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific DNA Repair Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America DNA Repair Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa DNA Repair Drugs Sales Breakdown by Type (2016-2021)
2 Global DNA Repair Drugs Market Competition by Company
2.1 Global Top Players by DNA Repair Drugs Sales (2016-2021)
2.2 Global Top Players by DNA Repair Drugs Revenue (2016-2021)
2.3 Global Top Players DNA Repair Drugs Price (2016-2021)
2.4 Global Top Manufacturers DNA Repair Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 DNA Repair Drugs Market Competitive Situation and Trends
2.5.1 DNA Repair Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by DNA Repair Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into DNA Repair Drugs Market
2.8 Key Manufacturers DNA Repair Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 DNA Repair Drugs Status and Outlook by Region
3.1 Global DNA Repair Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global DNA Repair Drugs Historic Market Size by Region
3.2.1 Global DNA Repair Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global DNA Repair Drugs Sales in Value by Region (2016-2021)
3.2.3 Global DNA Repair Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global DNA Repair Drugs Forecasted Market Size by Region
3.3.1 Global DNA Repair Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global DNA Repair Drugs Sales in Value by Region (2022-2027)
3.3.3 Global DNA Repair Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global DNA Repair Drugs by Application
4.1 DNA Repair Drugs Market Segment by Application
4.1.1 Oncological
4.1.2 Stroke
4.2 Global DNA Repair Drugs Market Size by Application
4.2.1 Global DNA Repair Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global DNA Repair Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global DNA Repair Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global DNA Repair Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global DNA Repair Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global DNA Repair Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global DNA Repair Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global DNA Repair Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global DNA Repair Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America DNA Repair Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe DNA Repair Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific DNA Repair Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America DNA Repair Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa DNA Repair Drugs Sales Breakdown by Application (2016-2021)
5 North America DNA Repair Drugs by Country
5.1 North America DNA Repair Drugs Historic Market Size by Country
5.1.1 North America DNA Repair Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America DNA Repair Drugs Sales in Value by Country (2016-2021)
5.2 North America DNA Repair Drugs Forecasted Market Size by Country
5.2.1 North America DNA Repair Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America DNA Repair Drugs Sales in Value by Country (2022-2027)
6 Europe DNA Repair Drugs by Country
6.1 Europe DNA Repair Drugs Historic Market Size by Country
6.1.1 Europe DNA Repair Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe DNA Repair Drugs Sales in Value by Country (2016-2021)
6.2 Europe DNA Repair Drugs Forecasted Market Size by Country
6.2.1 Europe DNA Repair Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe DNA Repair Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific DNA Repair Drugs by Region
7.1 Asia-Pacific DNA Repair Drugs Historic Market Size by Region
7.1.1 Asia-Pacific DNA Repair Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific DNA Repair Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific DNA Repair Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific DNA Repair Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific DNA Repair Drugs Sales in Value by Region (2022-2027)
8 Latin America DNA Repair Drugs by Country
8.1 Latin America DNA Repair Drugs Historic Market Size by Country
8.1.1 Latin America DNA Repair Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America DNA Repair Drugs Sales in Value by Country (2016-2021)
8.2 Latin America DNA Repair Drugs Forecasted Market Size by Country
8.2.1 Latin America DNA Repair Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America DNA Repair Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa DNA Repair Drugs by Country
9.1 Middle East and Africa DNA Repair Drugs Historic Market Size by Country
9.1.1 Middle East and Africa DNA Repair Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa DNA Repair Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa DNA Repair Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa DNA Repair Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa DNA Repair Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in DNA Repair Drugs Business
10.1 4SC AG
10.1.1 4SC AG Corporation Information
10.1.2 4SC AG Introduction and Business Overview
10.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 4SC AG DNA Repair Drugs Products Offered
10.1.5 4SC AG Recent Development
10.2 ARCAGY/ GINECO GROUP
10.2.1 ARCAGY/ GINECO GROUP Corporation Information
10.2.2 ARCAGY/ GINECO GROUP Introduction and Business Overview
10.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 4SC AG DNA Repair Drugs Products Offered
10.2.5 ARCAGY/ GINECO GROUP Recent Development
10.3 Bristol Myers Squibb
10.3.1 Bristol Myers Squibb Corporation Information
10.3.2 Bristol Myers Squibb Introduction and Business Overview
10.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
10.3.5 Bristol Myers Squibb Recent Development
10.4 British Columbia Cancer Agency
10.4.1 British Columbia Cancer Agency Corporation Information
10.4.2 British Columbia Cancer Agency Introduction and Business Overview
10.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
10.4.5 British Columbia Cancer Agency Recent Development
10.5 Cambridge University Hospitals NHS Foundation Trust
10.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
10.5.2 Cambridge University Hospitals NHS Foundation Trust Introduction and Business Overview
10.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
10.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
10.6 Genentech
10.6.1 Genentech Corporation Information
10.6.2 Genentech Introduction and Business Overview
10.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Genentech DNA Repair Drugs Products Offered
10.6.5 Genentech Recent Development
10.7 Georgetown University
10.7.1 Georgetown University Corporation Information
10.7.2 Georgetown University Introduction and Business Overview
10.7.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Georgetown University DNA Repair Drugs Products Offered
10.7.5 Georgetown University Recent Development
10.8 German Breast Group
10.8.1 German Breast Group Corporation Information
10.8.2 German Breast Group Introduction and Business Overview
10.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 German Breast Group DNA Repair Drugs Products Offered
10.8.5 German Breast Group Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Corporation Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Jiangsu Hengrui Medicine
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 DNA Repair Drugs Product Category, Application and Specification
10.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Jiangsu Hengrui Medicine Recent Development
10.11 Johnson & Johnson
10.11.1 Johnson & Johnson Corporation Information
10.11.2 Johnson & Johnson Introduction and Business Overview
10.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Johnson & Johnson DNA Repair Drugs Products Offered
10.11.5 Johnson & Johnson Recent Development
10.12 Jonsson Comprehensive Cancer Center
10.12.1 Jonsson Comprehensive Cancer Center Corporation Information
10.12.2 Jonsson Comprehensive Cancer Center Introduction and Business Overview
10.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Products Offered
10.12.5 Jonsson Comprehensive Cancer Center Recent Development
10.13 Karyopharm Therapeutics
10.13.1 Karyopharm Therapeutics Corporation Information
10.13.2 Karyopharm Therapeutics Introduction and Business Overview
10.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Karyopharm Therapeutics DNA Repair Drugs Products Offered
10.13.5 Karyopharm Therapeutics Recent Development
10.14 KuDOS Pharmaceuticals
10.14.1 KuDOS Pharmaceuticals Corporation Information
10.14.2 KuDOS Pharmaceuticals Introduction and Business Overview
10.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Products Offered
10.14.5 KuDOS Pharmaceuticals Recent Development
10.15 National Health Service
10.15.1 National Health Service Corporation Information
10.15.2 National Health Service Introduction and Business Overview
10.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.15.4 National Health Service DNA Repair Drugs Products Offered
10.15.5 National Health Service Recent Development
10.16 National Institutes of Health
10.16.1 National Institutes of Health Corporation Information
10.16.2 National Institutes of Health Introduction and Business Overview
10.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.16.4 National Institutes of Health DNA Repair Drugs Products Offered
10.16.5 National Institutes of Health Recent Development
10.17 Tesaro
10.17.1 Tesaro Corporation Information
10.17.2 Tesaro Introduction and Business Overview
10.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Tesaro DNA Repair Drugs Products Offered
10.17.5 Tesaro Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 DNA Repair Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 DNA Repair Drugs Industrial Chain Analysis
11.4 DNA Repair Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 DNA Repair Drugs Distributors
12.3 DNA Repair Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
